Application 021192

Type
NDA
Sponsor
NOVARTIS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001LESCOL XLFLUVASTATIN SODIUMTABLET, EXTENDED RELEASE;ORALEQ 80MG BASEYesYes

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
0078-0354Lescolfluvastatin sodiumNovartis Pharmaceuticals CorporationNDACurrent
0078-0354Lescolfluvastatin sodiumNovartis Pharmaceuticals CorporationNDACurrent
0078-0354Lescolfluvastatin sodiumNovartis Pharmaceuticals CorporationNDACurrent
0078-0354Lescolfluvastatin sodiumNovartis Pharmaceuticals CorporationNDACurrent
0078-0354Lescolfluvastatin sodiumNovartis Pharmaceuticals CorporationNDACurrent
0078-0354Lescolfluvastatin sodiumNovartis Pharmaceuticals CorporationNDACurrent
0078-0354Lescolfluvastatin sodiumNovartis Pharmaceuticals CorporationNDACurrent
0781-5370FLUVASTATIN SODIUMfluvastatin sodiumSandoz IncNDA AUTHORIZED GENERICCurrent
0781-8017FLUVASTATIN SODIUMfluvastatin sodiumSandoz IncNDA AUTHORIZED GENERICCurrent
0781-8017FLUVASTATIN SODIUMfluvastatin sodiumSandoz IncNDA AUTHORIZED GENERICCurrent
0781-8017FLUVASTATIN SODIUMfluvastatin sodiumSandoz IncNDA AUTHORIZED GENERICCurrent
68151-4471Lescolfluvastatin sodiumCarilion Materials ManagementNDACurrent

Documents

DocumentSubmission typeDate
76680SUPPL 2023-11-29
76674SUPPL 2023-11-29
64727SUPPL2020-09-29
64700SUPPL2020-09-28
49282SUPPL2017-08-08
49273SUPPL2017-08-08
36322SUPPL2012-11-06
4608SUPPL2012-11-05
21502SUPPL2012-03-30
44472SUPPL2012-02-28
36321SUPPL2012-02-28
4607SUPPL2012-02-28
36320SUPPL2011-06-28
27032SUPPL2011-06-28
42014SUPPL2008-08-01
21501SUPPL2008-08-01
36319SUPPL2007-06-14
27031SUPPL2007-06-14
27030SUPPL2006-04-13
4605SUPPL2006-04-13
14617SUPPL2006-04-12
14616SUPPL2006-04-12
36318SUPPL2006-04-05
4606SUPPL2006-04-05
27029SUPPL2005-01-11
14615SUPPL2005-01-11
14612ORIG2004-06-08
42013ORIG2004-03-24
27028SUPPL2003-06-08
14614SUPPL2003-06-08
14613SUPPL2003-05-01
36317SUPPL2002-09-06
4604SUPPL2002-09-06
27027ORIG2000-10-06